Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED)…
AI-Powered Heart Failure Detection Technology Recognized Among Asia-Pacific's Top 20 MedTech Startups TOKYO, May 29, 2025 /PRNewswire/ -- Simplex Quantum,…
Data presented by Delix Therapeutics at the 2025 American Society of Clinical Psychopharmacology (ASCP) Conference confirms the NeuLogiq® Platform is…
MARLBOROUGH, Mass., May 28, 2025 /PRNewswire/ -- Quantiphi, an AI-first digital engineering company, today unveiled Phi Labs by Quantiphi, the formal…
Collaboration Leverages the Foundation's IBD Plexus® Research Accelerator with PhaseV's AI/ML Solutions to Overcome Key Challenges in Clinical Development and Enhance…
Industry Leader with 30+ Years of Experience Will Drive Strategic Growth and Partnerships SCOTTSDALE, Ariz., May 27, 2025 /PRNewswire/ --…
LAS VEGAS, May 27, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner,…
Former HHS Leader and Digital Health Pioneer Brings Unparalleled Experience to Strengthen the Firm’s Growing PracticeWASHINGTON--(BUSINESS WIRE)--Wilson Sonsini Goodrich &…
PITTSBURGH, May 27, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued…
DSMB recommended the continuation of trial as planned Topline data expected in Q3 2025 NEW HAVEN, Conn., May 27, 2025…